Edgewise Therapeutics Target Price

Analysts' average 12-month price target for Edgewise Therapeutics is $50.

Get informed when a big investor buys or sells

+ Follow

Share Price

$44.11

Average Target Price

$49.92

13.2% upside

12 analysts in the last 4 months

High: $66 | Low: $32

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-11	Goldman Sachs	$36	18.4% downside
2026-07-20	Evercore ISICory Kasimov	$55	24.7% upside
2026-07-09	Oppenheimer	$51	15.6% upside
2026-07-06	GuggenheimDebjit Chattopadhyay	$51	15.6% upside
2026-06-17	RBC Capital	$59	33.8% upside
2026-06-17	Goldman SachsPaul Choi	$32	27.5% downside
2026-06-16	Leerink Partners	$52	17.9% upside
2026-06-02	H.C. Wainwright	$45	2% upside
2026-06-02	RBC CapitalLeonid Timashev	$48	8.8% upside
2026-06-01	Raymond JamesMartin Auster	$66	49.6% upside
2026-06-01	WedbushLaura Chico	$52	17.9% upside
2026-05-06	Truist Financial	$52	17.9% upside
2026-03-10	Raymond JamesMartin Auster	$46	4.3% upside
2026-02-26	Evercore ISICory Kasimov	$45	2% upside
2026-02-26	Stifel NicolausJames Condulis	$25	43.3% downside
2025-09-24	Goldman Sachs	$20	54.7% downside
2025-03-07	Scotiabank	$50	13.4% upside
2024-12-05	Truist FinancialSrikripa Devarakonda	$50	13.4% upside
2024-10-11	Piper SandlerYasmeen Rahimi	$51	15.6% upside
2024-09-20	RBC CapitalLeonid Timashev	$42	4.8% downside
2024-09-19	Leerink PartnersJoseph Schwartz	$42	4.8% downside
2024-07-01	Piper SandlerYasmeen Rahimi	$48	8.8% upside

Edgewise Therapeutics (EWTX) FAQ

Edgewise Therapeutics posts a target price of $50. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $50 for EWTX means covering analysts, on average, see the stock 13.2% upside of $44.11 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for EWTX's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Edgewise Therapeutics's other metric pages and overview cover the third.

Judging Edgewise Therapeutics against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $50 here, then scan peer and history charts to see if the gap is persistent.